Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Samonigg

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapyM D Green, H Koelbl, J Baselga, et al.
British Journal of Cancer|March 21, 2013
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trialG Pfeiler, H Stöger, P Dubsky, et al.
Zentralblatt Fur Chirurgie|March 4, 1999
[Therapy studies of the Austrian Breast Cancer Group (ABC)]R Jakesz, H Hausmaninger, H Samonigg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2013
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)R A Popescu, R Schäfer, R Califano, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2002
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapyM D Green, H Koelbl, J Baselga, et al.
British Journal of Cancer|March 21, 2013
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trialG Pfeiler, H Stöger, P Dubsky, et al.
Zentralblatt Fur Chirurgie|March 4, 1999
[Therapy studies of the Austrian Breast Cancer Group (ABC)]R Jakesz, H Hausmaninger, H Samonigg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2013
The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO)R A Popescu, R Schäfer, R Califano, et al.
Pageof 8